Edition:
United Kingdom

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

184.75INR
15 Dec 2017
Change (% chg)

Rs0.40 (+0.22%)
Prev Close
Rs184.35
Open
Rs185.95
Day's High
Rs188.35
Day's Low
Rs184.00
Volume
159,099
Avg. Vol
471,661
52-wk High
Rs230.40
52-wk Low
Rs155.00

Select another date:

Mon, Dec 11 2017

BRIEF-Suven Life Sciences Gets Product Patents In India, U.S.

* SAYS CO SECURES PRODUCT PATENTS IN INDIA AND USA Source text - http://bit.ly/2AtbqHG Further company coverage:

BRIEF-India's Suven Life Sciences Secures Product Patents In Eurasia, Norway

* PATENTS CORRESPONDS TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES Source text - http://bit.ly/2AUMl7N Further company coverage:

BRIEF-India's Suven Life Sciences gets product patents in Hong Kong,India & U.S.​

* Patents corresponds to new chemical entities for treatment of disorders associated with neurodegenerative diseases

BRIEF-India's Suven Life Sciences gets product patent in Singapore

* Gets product patent from Singapore related to new chemical entities for treating disorders associated with neurodegenerative diseases Source text - http://bit.ly/2ghXZxC Further company coverage:

BRIEF-Suven Life Sciences gets product patent in New Zealand​

* Product patent corresponds to New Chemical Entities (NCEs) for treatment of disorders associated with neurodegenerative diseases‍​‍​

BRIEF-Suven Life Sciences secures product patents in India, Japan

* Says Suven Life Sciences secures product patents in India and Japan

BRIEF-Suven Life Sciences gets product patent in Japan​

* Patent for new chemical entities for the treatment of disorders associated with neurodegenerative diseases

BRIEF-Suven Life Sciences secures process patents in Europe, Japan and New Zealand

* Patents for new chemical entities for treatment of disorders associated with neurodegenerative diseases Source text: (http://bit.ly/2vKB7xV) Further company coverage:

BRIEF-India's Suven Life Sciences June-qtr profit falls

* June quarter net profit 295.7 million rupees versus 325.8 million rupees year ago

BRIEF-Suven Life Sciences secures product patent in Australia

* Says Suven Life Sciences secures a product patent in Australia

Select another date: